ALBAlbemarle Corporation

Basic Materials

$101.29+26% 1Y

$101.29

$79.4852 weeks$215.07

Is the price fair?

Fair

Neither cheap nor expensive: modest expectations priced in, but at the top of its own P/E range and rich vs its sector.

1 good, 2 to watch

What the price assumes~+1% a year

Priced for ~1% a year FCF growth. Little growth is priced in even as revenue fell 15% a year over three years, potential value, or a value trap.

Vs its own P/E rangedearer than 78% of its own historyderived

Expensive vs its own history: P/E 45.8 vs a 20.9 median over 32 quarters (+119% vs median).

Vs sector (EV/EBIT)76.0×

Sector median 18.9× across 51 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF yieldbetter than 71% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What ALB's price assumes

Today's price asks for 1.0% free cash flow growth a year; over the last three years Albemarle Corporation delivered 12%, less than the record.

3.20

Price / sales · no trailing P/E on file: measured against sales instead

Free cash flow yield: 7.1%
Free cash flow yield · Specialty Chemicals median 4.7%
Growth the price implies: +1.0%
Growth the price implies · The price pays for +1.0% free cash flow growth a year for a decade; the business has delivered +12% a year over the last three.
Price / book: 1.84
Price / book · today's price, trailing year to Jun 30, 2026